Calcium channel blockers and beta-blockers used for hypertension generally pose no absorption conflict, but your PlexusDx provider should review your complete medication list before prescribing
This dual agonism allows the drug to lower glucose levels and reduce weight, but the side effects reported for Mounjaro are similar to other GLP-1 agonists
Retatrutide Retatrutide represents another approach to multi-pathway activation, functioning as a triple agonist (GIP/GLP-1/glucagon) in a single molecule: Cagrilintide + GLP-1 Approach: Two separate injections Amylin + GLP-1 pathways Established safety profile for each component Flexible dose adjustment of each component Retatrutide Approach: Single injection GIP + GLP-1 + Glucagon pathways Novel triple mechanism in one molecule Fixed ratio of pathway activation Both approaches show promise for significant metabolic benefits, though they achieve multi-pathway activation through different strategies
Zhao S., et al.) used mouse or rat models of obesity, diabetes, or glucose intolerance
Older adults are more likely to be taking several medications at once, which changes the risk calculation
Nature 379 : 449451
